0001704400-18-000001.txt : 20180425 0001704400-18-000001.hdr.sgml : 20180425 20180425161634 ACCESSION NUMBER: 0001704400-18-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180425 DATE AS OF CHANGE: 20180425 EFFECTIVENESS DATE: 20180425 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Anelixis Therapeutics, Inc. CENTRAL INDEX KEY: 0001704400 IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-310988 FILM NUMBER: 18774543 BUSINESS ADDRESS: STREET 1: 300 TECHNOLOGY SQUARE, SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02130 BUSINESS PHONE: 617-441-7200 MAIL ADDRESS: STREET 1: 300 TECHNOLOGY SQUARE, SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02130 D 1 primary_doc.xml X0708 D LIVE 0001704400 Anelixis Therapeutics, Inc. 300 TECHNOLOGY SQUARE, SUITE 400 CAMBRIDGE MA MASSACHUSETTS 02139 617-441-7200 DELAWARE Anelixis Pharmaceuticals, Inc. None Corporation true 2015 AUGIE NIETO c/o ANELIXIS THERAPEUTICS, INC. 300 TECHNOLOGY SQUARE, SUITE 400 CAMBRIDGE MA MASSACHUSETTS 02139 Director STEVEN PERRIN c/o ANELIXIS THERAPEUTICS, INC. 300 TECHNOLOGY SQUARE, SUITE 400 CAMBRIDGE MA MASSACHUSETTS 02139 Executive Officer Director WALTER C. OGIER c/o ANELIXIS THERAPEUTICS, INC. 300 TECHNOLOGY SQUARE, SUITE 400 CAMBRIDGE MA MASSACHUSETTS 02139 Director MAEVE MCNALLY c/o ANELIXIS THERAPEUTICS, INC. 300 TECHNOLOGY SQUARE, SUITE 400 CAMBRIDGE MA MASSACHUSETTS 02139 Executive Officer Biotechnology Decline to Disclose 06b false 2018-04-10 false true false 0 4500000 2574131 1925869 false 6 0 0 0 false Anelixis Therapeutics, Inc. STEVEN PERRIN STEVEN PERRIN PRESIDENT 2018-04-25